Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Adaptive, Randomized, Double-blind, Single-center, Placebo-controlled Phase I Study Evaluating ECG Effects, Safety and Pharmacokinetics of Single Ascending Doses of [6R]-5,10-Methylene Tetrahydrofolate (Modufolin for Injection, 100mg) in Healthy Male Volunteers

Next Previous
X
Search
Trial Profile

An Adaptive, Randomized, Double-blind, Single-center, Placebo-controlled Phase I Study Evaluating ECG Effects, Safety and Pharmacokinetics of Single Ascending Doses of [6R]-5,10-Methylene Tetrahydrofolate (Modufolin for Injection, 100mg) in Healthy Male Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Folitixorin (Primary)
  • Indications Colorectal cancer; Folic acid deficiency; Rectal cancer
  • Focus Adverse reactions
  • Sponsors Isofol Medical

    • Most Recent Events

    • 10 Oct 2017 Status changed from recruiting to completed.
    • 05 Jul 2017 According to an Isofol Medical media release, the first six patients have been enrolled and dosed in this study. This study is part of the regulatory documentation required for an oncology drug to be granted approval.
    • 05 Jul 2017 Status changed from not yet recruiting to recruiting according to an Isofol Medical media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top